Iron Horse Wealth Management LLC Lowers Holdings in UnitedHealth Group Incorporated $UNH

Iron Horse Wealth Management LLC cut its position in UnitedHealth Group Incorporated (NYSE:UNH) by 7.3% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,048 shares of the healthcare conglomerate’s stock after selling 83 shares during the quarter. Iron Horse Wealth Management LLC’s holdings in UnitedHealth Group were worth $327,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently made changes to their positions in the stock. Simplicity Wealth LLC increased its holdings in shares of UnitedHealth Group by 141.5% in the 2nd quarter. Simplicity Wealth LLC now owns 19,077 shares of the healthcare conglomerate’s stock worth $5,952,000 after buying an additional 11,179 shares during the last quarter. Brown Miller Wealth Management LLC increased its holdings in shares of UnitedHealth Group by 9.8% in the 2nd quarter. Brown Miller Wealth Management LLC now owns 7,228 shares of the healthcare conglomerate’s stock worth $2,255,000 after buying an additional 648 shares during the last quarter. OLD National Bancorp IN increased its holdings in shares of UnitedHealth Group by 5.2% in the 2nd quarter. OLD National Bancorp IN now owns 53,643 shares of the healthcare conglomerate’s stock worth $16,735,000 after buying an additional 2,664 shares during the last quarter. Highland Capital Management LLC increased its holdings in shares of UnitedHealth Group by 26.8% in the 2nd quarter. Highland Capital Management LLC now owns 13,235 shares of the healthcare conglomerate’s stock worth $4,129,000 after buying an additional 2,800 shares during the last quarter. Finally, MBL Wealth LLC grew its holdings in shares of UnitedHealth Group by 48.2% during the 2nd quarter. MBL Wealth LLC now owns 3,160 shares of the healthcare conglomerate’s stock valued at $986,000 after purchasing an additional 1,028 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have recently commented on the stock. Truist Financial raised their target price on shares of UnitedHealth Group from $310.00 to $365.00 and gave the stock a “buy” rating in a research report on Tuesday, September 9th. UBS Group reaffirmed a “buy” rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $440.00 price target on shares of UnitedHealth Group in a research note on Tuesday, August 26th. Barclays boosted their target price on shares of UnitedHealth Group from $337.00 to $352.00 and gave the company an “overweight” rating in a research report on Thursday, September 4th. Finally, KeyCorp dropped their price target on shares of UnitedHealth Group from $400.00 to $350.00 and set an “overweight” rating for the company in a research report on Wednesday, July 30th. Sixteen equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and four have given a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average price target of $358.95.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $360.17 on Friday. The company has a market cap of $326.20 billion, a price-to-earnings ratio of 15.61, a PEG ratio of 2.34 and a beta of 0.47. The firm’s fifty day moving average is $307.84 and its 200 day moving average is $354.55. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to analysts’ expectations of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. UnitedHealth Group’s revenue for the quarter was up 12.9% compared to the same quarter last year. During the same period in the previous year, the company earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were paid a $2.21 dividend. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. UnitedHealth Group’s dividend payout ratio is currently 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.